TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25936237

Group type: EXPERIMENTAL
Intervention: Heart-shaped intrauterine balloon
Number of subjects: 201

Group type: COMPARATOR
Intervention: Intrauterine contraceptive device (IUD)
Number of subjects: 201
Study: 23369879

Group type: EXPERIMENTAL
Intervention: 10mg amlodipine/80mg atorvastatin (test product)
Number of subjects: 29

Group type: COMPARATOR
Intervention: CADUET(®) (reference product)
Number of subjects: 29
Study: 21900198

Group type: EXPERIMENTAL
Intervention: R-CHOP (CHOP with rituximab)
Number of subjects: 512

Group type: COMPARATOR
Intervention: CHOP (without rituximab)
Number of subjects: 512
Study: 19473629

Group type: EXPERIMENTAL
Intervention: High-dose ARB (losartan 200 mg/day)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Normal dose ARB (losartan 100 mg/day)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Normal dose ACEI (20 mg/day)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Low-dose ACEI (10 mg/day)
Number of subjects: 207
Study: 16115616

Group type: EXPERIMENTAL
Intervention: Children's knowledge of number words beyond those they have mastered
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Children's productive symbolic system for representing number
Number of subjects: 0
Study: 15558520

Group type: EXPERIMENTAL
Intervention: Continuous venovenous hemodialysis (CVVHD)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intermittent hemodialysis (IHD)
Number of subjects: 80
Study: 11783049

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 9519234

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 2 mg daily via metered-dose inhaler and Volumatic
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nebulized budesonide (nBUD)
Number of subjects: 30
Study: 8592675

Group type: EXPERIMENTAL
Intervention: Nefazodone (NEF) infused into the proximal intestine (400 mg over 5 hours)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nefazodone (NEF) infused into the distal intestine (400 mg over 5 hours)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Nefazodone (NEF) administered orally (10 divided doses over 4.5 hours)
Number of subjects: 10
Study: 2528028

Group type: EXPERIMENTAL
Intervention: abdominal crunch (AC) weight machine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: seated incline (SI) weight machine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: incline sit-up (ISU) exercise
Number of subjects: 45
Study: 793781

Group type: EXPERIMENTAL
Intervention: Nethaprin Dospan (active drug)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 31155953

Group type: EXPERIMENTAL
Intervention: Broccoli sprout extract (BSE) 200 µmol daily
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 30385101

Group type: EXPERIMENTAL
Intervention: Narrative Medicine (NM) workshop
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 103
Study: 28777758

Group type: EXPERIMENTAL
Intervention: Exenatide 2mg (Bydureon) administered via once-weekly subcutaneous injections for 48 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24585506

Group type: EXPERIMENTAL
Intervention: Gefitinib 250 mg orally daily
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 37
Study: 22211733

Group type: EXPERIMENTAL
Intervention: Basal plus 3.5 g l-Lys/kg diet (T2)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Basal plus 1.5 g l-Leu/kg diet (T3)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Basal plus 3.5 g l-Lys plus 1.5 g l-Leu/kg diet (T4)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Basal diet (T1)
Number of subjects: 20
Study: 22151477

Group type: EXPERIMENTAL
Intervention: Vitamin/mineral supplement
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 19957624

Group type: EXPERIMENTAL
Intervention: Influenza vaccine from lot 1
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Influenza vaccine from lot 2
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Influenza vaccine from lot 3
Number of subjects: 566

Group type: COMPARATOR
Intervention: Licensed control vaccine
Number of subjects: 566
Study: 16362241

Group type: EXPERIMENTAL
Intervention: Maternal perceptions of neighborhood characteristics (collective efficacy, barriers to services, negative neighbor affects, probability of child status attainment success, overall neighborhood rating)
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Family income
Number of subjects: 576
Study: 15488111

Group type: EXPERIMENTAL
Intervention: Out-patient interventions
Number of subjects: 563
Study: 11129341

Group type: EXPERIMENTAL
Intervention: TNFRSF6 GG-genotype in APOE4 carriers
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: TNFRSF6 GG-genotype in EOAD cases
Number of subjects: 675

Group type: COMPARATOR
Intervention: TNFRSF6 GG-genotype in initial study
Number of subjects: 675

Group type: COMPARATOR
Intervention: TNFRSF6 GG-genotype overall association
Number of subjects: 675
Study: 8839875

Group type: EXPERIMENTAL
Intervention: PBSCT
Number of subjects: 40

Group type: COMPARATOR
Intervention: BMT
Number of subjects: 40
Study: 1771375

Group type: EXPERIMENTAL
Intervention: Duraphat (2.26% fluoride), applied every 6 months, n = 185
Number of subjects: 495

Group type: COMPARATOR
Intervention: Carex (1.8% fluoride), applied every 6 months, n = 165
Number of subjects: 495
Study: 6943174

Group type: EXPERIMENTAL
Intervention: Experimental method (guided systematic approach with detailed checklists and exhaustive faculty feedback)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control method (traditional teaching method used at the University of North Carolina School of Dentistry)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Experimental method
Number of subjects: 88
Study: 31112203

Group type: EXPERIMENTAL
Intervention: Unmodified α‐1,3‐glucan solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random silencing of hydrogen bonding donor sites
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Specific silencing of the hydrogen-bonding site on the C6 carbon
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher hydrogen bond strengths
Number of subjects: 0
Study: 28716797

Group type: EXPERIMENTAL
Intervention: Regular low-dose extended-release morphine
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Upward titration of morphine after initial benefit
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study: 26036212

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogen at 0.625 mg/d (n=5279)
Number of subjects: 10739

Group type: COMPARATOR
Intervention: Placebo (n=5409)
Number of subjects: 10739
Study: 25287554

Group type: EXPERIMENTAL
Intervention: Hypnotic analgesia
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Meditation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham transcranial direct stimulation
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: EEG biofeedback
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation
Number of subjects: 30
Study: 22843170

Group type: EXPERIMENTAL
Intervention: Balneotherapy with sulphurous thermal water (20 min per occasion, 15 times over 3 weeks)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Warm tap water (control group)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Balneotherapy with sulphurous thermal water
Number of subjects: 47
Study: 20127540

Group type: COMPARATOR
Intervention: Emotion suppression
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Emotion allowance
Number of subjects: 34
Study: 17650793

Group type: EXPERIMENTAL
Intervention: Extract of Ginkgo biloba (EGb) given additionally to routine treatment for 2 months.
Number of subjects: 63

Group type: COMPARATOR
Intervention: Routine treatment (control group).
Number of subjects: 63
Study: 16081619

Group type: EXPERIMENTAL
Intervention: Prolonged electrical muscle stimulation (EMS)
Number of subjects: 15
Study: 12105833

Group type: EXPERIMENTAL
Intervention: 15N soy protein
Number of subjects: 13

Group type: COMPARATOR
Intervention: 15N milk protein
Number of subjects: 13
Study: 9921569

Group type: EXPERIMENTAL
Intervention: Guided imagery audiotape listened to once a day for the duration of the study
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (no guided imagery intervention)
Number of subjects: 53
Study: 8804449

Group type: EXPERIMENTAL
Intervention: Ultrasonography screening
Number of subjects: 2025

Group type: COMPARATOR
Intervention: Repeat sonography
Number of subjects: 2025
Study: 2500070

Group type: EXPERIMENTAL
Intervention: PSK (oral) in addition to mitomycin C and 5-FU for over 3 years
Number of subjects: 462

Group type: COMPARATOR
Intervention: Mitomycin C intravenously and 5-FU orally for 6 months
Number of subjects: 462
Study: 5306538

Group type: EXPERIMENTAL
Intervention: Single dose of cholera vaccine
Number of subjects: 40000

Group type: EXPERIMENTAL
Intervention: Two doses of cholera vaccine at an interval of 1 month
Number of subjects: 40000

Group type: EXPERIMENTAL
Intervention: Two doses of cholera vaccine
Number of subjects: 40000
Study: 31017492

Group type: EXPERIMENTAL
Intervention: Artemether emulsion (1%)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Metronidazole emulsion (3%)
Number of subjects: 130
Study: 28679471

Group type: EXPERIMENTAL
Intervention: Endoscopically assisted selective neck dissection (SND)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 60
Study: 25346994

Group type: EXPERIMENTAL
Intervention: Time of Day (TOD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caffeine intake controlled
Number of subjects: 0
Study: 22964356

Group type: EXPERIMENTAL
Intervention: Adenosine (1.2 mmol/L)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hyperkalemic cardioplegia
Number of subjects: 60
Study: 21691245

Group type: EXPERIMENTAL
Intervention: Hand sanitizer and respiratory hygiene education in intervention schools
Number of subjects: 3360

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 3360
Study: 18205730

Group type: EXPERIMENTAL
Intervention: Intervention group consuming high amounts of six selected vegetables (target of 350 g/day for 65 days)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group avoiding the same six vegetables
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Comparison of both groups
Number of subjects: 94
Study: 21629359

Group type: COMPARATOR
Intervention: Negative expiratory pressure (NEP) at -5 cm H(2)O, seated
Number of subjects: 60

Group type: COMPARATOR
Intervention: Negative expiratory pressure (NEP) at -10 cm H(2)O, seated
Number of subjects: 60

Group type: COMPARATOR
Intervention: Negative expiratory pressure (NEP) at -5 cm H(2)O, supine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Negative expiratory pressure (NEP) at -10 cm H(2)O, supine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Negative expiratory pressure (NEP)
Number of subjects: 60
Study: 16415629

Group type: EXPERIMENTAL
Intervention: Reality therapy program
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 12477679

Group type: EXPERIMENTAL
Intervention: 50% nitrous oxide in O2
Number of subjects: 54

Group type: COMPARATOR
Intervention: 100% oxygen (control group)
Number of subjects: 54
Study: 9648959

Group type: EXPERIMENTAL
Intervention: salmeterol 50 microg b.d.
Number of subjects: 49

Group type: COMPARATOR
Intervention: placebo b.d.
Number of subjects: 49
Study: 8018374

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (31.5 Gy in 18 fractions)
Number of subjects: 0
Study: 2491075

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion
Number of subjects: 17

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 17
Study: 11204290

Group type: EXPERIMENTAL
Intervention: Quinapril
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 30877638

Group type: EXPERIMENTAL
Intervention: In-home intervention providing strategies to manage behavioral symptoms and caregiver stress, 8 sessions over 3 months.
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: In-home intervention (indirectly through time spent assisting PwD).
Number of subjects: 226
Study: 30403756

Group type: EXPERIMENTAL
Intervention: Six-month lifestyle intervention program
Number of subjects: 577
Study: 27358210

Group type: EXPERIMENTAL
Intervention: Brodalumab 210 mg
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Brodalumab 140 mg
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Brodalumab 210 mg and 140 mg
Number of subjects: 145
Study: 25298573

Group type: EXPERIMENTAL
Intervention: Boswellia serrata (125 mg, 2 capsules)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 22616314

Group type: EXPERIMENTAL
Intervention: Fixed ratio of morphine and oxycodone combinations (MOX) at ratios 3:2 in study A and 1:2 in study B
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fixed ratio of morphine and oxycodone combinations (MOX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morphine monotherapy
Number of subjects: 0
Study: 20529365

Group type: EXPERIMENTAL
Intervention: 2-page survey
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: 4-page survey
Number of subjects: 780

Group type: COMPARATOR
Intervention: Letter pre-notification
Number of subjects: 780

Group type: COMPARATOR
Intervention: Postcard pre-notification
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: 4-page survey for individuals in their 20s
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: 2-page survey for individuals in their 20s
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: 4-page survey for individuals in their 30s
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: 2-page survey for individuals in their 30s
Number of subjects: 780
Study: 17589281

Group type: EXPERIMENTAL
Intervention: Family-based behavioral therapy plus sibutramine
Number of subjects: 79

Group type: COMPARATOR
Intervention: Family-based behavioral therapy plus placebo
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Both treatment groups (regardless of intervention)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Family-based behavioral therapy plus sibutramine (Caucasian group)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Family-based behavioral therapy plus sibutramine (African American group)
Number of subjects: 79
Study: 15114376

Group type: EXPERIMENTAL
Intervention: Plant-based low-fat diet with flexible fat content (20% or 15% of energy as fat)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Plant-based low-fat diet with flexible fat content
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group consuming a plant-based low-fat diet with 20% of energy as fat
Number of subjects: 32
Study: 11880813

Group type: EXPERIMENTAL
Intervention: Power training (P)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stretching (S)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of power and stretch training (PS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 0
Study: 9813560

Group type: EXPERIMENTAL
Intervention: GSNO 10(‐6) M (in vitro)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: GSNO (40 nmol/min) (in vivo)
Number of subjects: 24
Study: 8132135

Group type: EXPERIMENTAL
Intervention: Octreotide (3 x 100 micrograms/day s.c.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2592583

Group type: EXPERIMENTAL
Intervention: Nitrendipine 20 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 4467872

Group type: EXPERIMENTAL
Intervention: Ferrous sulphate tablets, BP, given before meals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ferrous sulphate tablets, BP, given after meals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sustained release formulation of ferrous salts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other ferrous salts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Liquid iron preparation
Number of subjects: 0
Study: 29804376

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil
Number of subjects: 106

Group type: COMPARATOR
Intervention: Adefovir dipivoxil
Number of subjects: 106
Study: 28245911

Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate (CS)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Acetaminophen (ACT)
Number of subjects: 70
Study: 25901427

Group type: COMPARATOR
Intervention: Placebo-Placebo
Number of subjects: 1103

Group type: COMPARATOR
Intervention: Prednisolone-Placebo
Number of subjects: 1103

Group type: COMPARATOR
Intervention: Pentoxifylline-Placebo
Number of subjects: 1103

Group type: EXPERIMENTAL
Intervention: Prednisolone-Pentoxifylline
Number of subjects: 1103

Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 1103

Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 1103

Group type: COMPARATOR
Intervention: No Prednisolone
Number of subjects: 1103
Study: 24008808

Group type: EXPERIMENTAL
Intervention: Brimonidine-timolol fixed combination
Number of subjects: 90

Group type: COMPARATOR
Intervention: Brimonidine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Timolol
Number of subjects: 90
Study: 21498674

Group type: EXPERIMENTAL
Intervention: Ofatumumab 500 mg
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Ofatumumab 1000 mg
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: O-FC (both doses)
Number of subjects: 61
Study: 19080708

Group type: EXPERIMENTAL
Intervention: Lumbar plexus block (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Epidural block (Group B)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 15982795

Group type: EXPERIMENTAL
Intervention: Fruit teas (various types)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.2% citric acid solution (positive control)
Number of subjects: 0
Study: 12818970

Group type: EXPERIMENTAL
Intervention: Topical nasal treatment with mupirocin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nontreatment (control group)
Number of subjects: 60
Study: 10977438

Group type: EXPERIMENTAL
Intervention: Oral levofloxacin
Number of subjects: 211

Group type: COMPARATOR
Intervention: Oral cefuroxime axetil
Number of subjects: 211
Study: 8875535

Group type: EXPERIMENTAL
Intervention: TPN supplemented with 10 mg of iron as iron dextran daily (group 2)
Number of subjects: 23

Group type: COMPARATOR
Intervention: TPN without iron (group 1)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 23
Study: 1671884

Group type: EXPERIMENTAL
Intervention: Ditiocarb sodium (400 mg/m2 orally for 24 weeks)
Number of subjects: 389

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Ditiocarb sodium
Number of subjects: 389
Study: 6558741

Group type: EXPERIMENTAL
Intervention: Bedtime story tape recorded by the parent
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no bedtime story)
Number of subjects: 18
Study: 31825025

Group type: EXPERIMENTAL
Intervention: Adhesive flash-free (FF) brackets
Number of subjects: 50

Group type: COMPARATOR
Intervention: Adhesive pre-coated (APC) brackets
Number of subjects: 50
Study: 29576447

Group type: EXPERIMENTAL
Intervention: Telephone support for breastfeeding (weekly for 2 months, then every 2 weeks until 6 months)
Number of subjects: 380

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Telephone support for breastfeeding
Number of subjects: 380
Study: 26851398

Group type: EXPERIMENTAL
Intervention: Rolapitant (180 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study: 24472061

Group type: EXPERIMENTAL
Intervention: Projected LV lead position using standard fluoroscopy systems
Number of subjects: 16

Group type: COMPARATOR
Intervention: Validation group (n = 8)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Application group (n = 8)
Number of subjects: 16
Study: 23235967

Group type: EXPERIMENTAL
Intervention: Ultrasonography plus KUB assessment
Number of subjects: 139

Group type: COMPARATOR
Intervention: Intravenous urography (IVU)
Number of subjects: 139
Study: 20659762

Group type: EXPERIMENTAL
Intervention: 81 mg aspirin daily for two months
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 325 mg aspirin daily for two months
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Chronic ASA therapy
Number of subjects: 32

Group type: COMPARATOR
Intervention: All patients
Number of subjects: 32

Group type: COMPARATOR
Intervention: Brachial artery endothelial function via flow‐mediated dilation (BAFMD)
Number of subjects: 32
Study: 17986845

Group type: EXPERIMENTAL
Intervention: Radiotherapy and 5‐fluorouracil
Number of subjects: 476

Group type: COMPARATOR
Intervention: Radiotherapy and gemcitabine
Number of subjects: 476
Study: 15855578

Group type: EXPERIMENTAL
Intervention: 30 mg nateglinide
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 60 mg nateglinide
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 120 mg nateglinide
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 11923801

Group type: EXPERIMENTAL
Intervention: Azimilide 100 mg
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Azimilide 125 mg
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Combined Azimilide (100 and 125 mg)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study: 10615220

Group type: EXPERIMENTAL
Intervention: Parsley intervention (3.73‐4.49 mg apigenin/MJ)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Basic diet (control)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Parsley intervention
Number of subjects: 14
Study: 7793179

Group type: EXPERIMENTAL
Intervention: Succinylcholine 1.0‐1.5 mg kg‐1
Number of subjects: 1247

Group type: EXPERIMENTAL
Intervention: Succinylcholine in patients with newly discovered genotypes AK (5 patients) and AH (1 patient)
Number of subjects: 1247
Study: 1790064

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 109

Group type: COMPARATOR
Intervention: Flunarizine
Number of subjects: 109
Study: 6127968

Group type: EXPERIMENTAL
Intervention: Midazolam 0.1 mg/kg
Number of subjects: 2

Group type: COMPARATOR
Intervention: Diazepam 0.15 mg/kg
Number of subjects: 2
Study: 30371644

Group type: EXPERIMENTAL
Intervention: Weight management intervention
Number of subjects: 82

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 82